BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 27402816)

  • 1. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Multiplex Immunoassays for Quantification of IgG against Group B
    Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
    Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
    J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women.
    Dangor Z; Kwatra G; Izu A; Adrian P; van Niekerk N; Cutland CL; Adam Y; Velaphi S; Lala SG; Madhi SA
    J Infect Dis; 2015 Aug; 212(3):453-62. PubMed ID: 25651843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.
    Lin FY; Philips JB; Azimi PH; Weisman LE; Clark P; Rhoads GG; Regan J; Concepcion NF; Frasch CE; Troendle J; Brenner RA; Gray BM; Bhushan R; Fitzgerald G; Moyer P; Clemens JD
    J Infect Dis; 2001 Oct; 184(8):1022-8. PubMed ID: 11574917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns.
    Suara RO; Adegbola RA; Mulholland EK; Greenwood BM; Baker CJ
    J Natl Med Assoc; 1998 Feb; 90(2):109-14. PubMed ID: 9510625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants.
    Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
    Expert Rev Vaccines; 2015; 14(12):1651-60. PubMed ID: 26364978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
    Dangor Z; Lala SG; Kwatra G; Madhi SA
    Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
    Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
    Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
    Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
    Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
    J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
    Buurman ET; Timofeyeva Y; Gu J; Kim JH; Kodali S; Liu Y; Mininni T; Moghazeh S; Pavliakova D; Singer C; Singh S; Handke LD; Lotvin J; Prasad AK; Scully IL; Donald RGK; Jansen KU; Anderson AS
    J Infect Dis; 2019 Jun; 220(1):105-115. PubMed ID: 30778554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
    Edwards MS; Fuselier PA; Rench MA; Kasper DL; Baker CJ
    Infect Immun; 1984 May; 44(2):257-61. PubMed ID: 6370863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery.
    Campbell JR; Hillier SL; Krohn MA; Ferrieri P; Zaleznik DF; Baker CJ
    Obstet Gynecol; 2000 Oct; 96(4):498-503. PubMed ID: 11004347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.